Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn which commodities offer high returns to enhance your investment portfolio. Make informed decisions to grow your wealth.
26,939 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
Viking isn’t just another cruise line on the stock market. This article breaks down five reasons reasons Viking diffe...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
A seasoned market watcher outlines a bold bull case for Bitcoin and Ethereum, suggesting cryptocurrencies poised soar...
Looking for growth you can ride for years? This guide breaks down three powerhouse names—NVIDIA, Microsoft, and Alpha...
As markets swing and rates climb, investors increasingly turn to high-yield REITs for reliable cash flow. This report...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
A fast acquittal may clear charges, but the financial fallout can linger for years. This guide explains how the phras...
The Michael biopic reclaimed the top spot with a domestic 26.1M, while Prada 2 trailed in second. New releases also j...
Greg Abel is steering Berkshire’s AI strategy with a sizable move into Alphabet. This bold bet highlights how mega-ca...